Hansa Biopharma AB (HNSBF)
3.65
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Hansa Biopharma Total Assets (Quarterly): 93.30M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 93.30M |
| June 30, 2024 | 96.99M |
| March 31, 2024 | 77.96M |
| December 31, 2023 | 101.13M |
| September 30, 2023 | 107.29M |
| June 30, 2023 | 125.47M |
| March 31, 2023 | 144.85M |
| December 31, 2022 | 161.90M |
| September 30, 2022 | 124.00M |
| June 30, 2022 | 76.82M |
| March 31, 2022 | 96.31M |
| December 31, 2021 | 111.95M |
| September 30, 2021 | 124.22M |
| June 30, 2021 | 143.03M |
| March 31, 2021 | 150.35M |
| December 31, 2020 | 175.18M |
| September 30, 2020 | 170.26M |
| June 30, 2020 | 49.32M |
| March 31, 2020 | 53.80M |
| December 31, 2019 | 71.08M |
| September 30, 2019 | 75.17M |
| June 30, 2019 | 88.24M |
| March 31, 2019 | 96.63M |
| December 31, 2018 | 105.21M |
| September 30, 2018 | 64.15M |
| Date | Value |
|---|---|
| June 30, 2018 | 66.87M |
| March 31, 2018 | 77.64M |
| December 31, 2017 | 83.20M |
| September 30, 2017 | 24.02M |
| June 30, 2017 | 27.06M |
| March 31, 2017 | 29.80M |
| December 31, 2016 | 34.27M |
| September 30, 2016 | 18.52M |
| June 30, 2016 | 21.44M |
| March 31, 2016 | 25.09M |
| December 31, 2015 | 26.65M |
| September 30, 2015 | 28.64M |
| June 30, 2015 | 31.18M |
| March 31, 2015 | 6.352M |
| December 31, 2014 | 7.006M |
| June 30, 2014 | 11.23M |
| December 31, 2013 | 7.895M |
| June 30, 2013 | 8.536M |
| June 30, 2013 | 8.536M |
| December 31, 2012 | 9.743M |
| June 30, 2012 | 9.996M |
| June 30, 2012 | 9.996M |
| December 31, 2011 | 5.622M |
| June 30, 2011 | 8.423M |
| December 31, 2010 | 5.602M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
49.32M
Minimum
Jun 2020
175.18M
Maximum
Dec 2020
112.76M
Average
109.62M
Median
Total Assets (Quarterly) Benchmarks
| Abliva AB | 7.132M |
| Oncopeptides AB | 27.02M |
| BioInvent International AB | 107.86M |
| BioArctic AB | 106.66M |
| Camurus AB | 353.72M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 125.03M |
| Shareholders Equity (Quarterly) | -31.73M |
| Debt to Equity Ratio | -2.947 |
| Current Ratio | 2.451 |
| Net Debt Paydown Yield | -1.67% |